Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Jyong Biotech Ltd. Ordinary Shares, Common Stock

MENS

NMQ

$52.31

-$2.8

(-5.08%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$4.19B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

134.38K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$6.01 L

$61 H

$52.31

About Jyong Biotech Ltd. Ordinary Shares, Common Stock

Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan. more

Returns

Data is not properly formatted.

Time Frame	MENS		S&P500
1-Week Return	-4.56%%	%	0.59%%
1-Month Return	80.82%%	%	3.33%%
3-Month Return	417.41%%	%	9.45%%

Financials

	Dec '21	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	2.40M	2.83M	2.80M	2.06M	[{"date":"2021-12-31","value":84.98,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.87,"profit":true},{"date":"2024-12-31","value":72.68,"profit":true}]
Operating Income	(2.40M)	(2.83M)	(2.80M)	(2.06M)	[{"date":"2021-12-31","value":-240400000,"profit":false},{"date":"2022-12-31","value":-282900000,"profit":false},{"date":"2023-12-31","value":-279700000,"profit":false},{"date":"2024-12-31","value":-205600000,"profit":false}]
Total Non-Operating Income/Expense	(2.62M)	(4.56M)	(2.30M)	(1.99M)	[{"date":"2021-12-31","value":-262300000,"profit":false},{"date":"2022-12-31","value":-456100000,"profit":false},{"date":"2023-12-31","value":-230400000,"profit":false},{"date":"2024-12-31","value":-199100000,"profit":false}]
Pre-Tax Income	(4.20M)	(6.63M)	(4.40M)	(3.02M)	[{"date":"2021-12-31","value":-419800000,"profit":false},{"date":"2022-12-31","value":-663000000,"profit":false},{"date":"2023-12-31","value":-440000000,"profit":false},{"date":"2024-12-31","value":-301900000,"profit":false}]
Income Taxes	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	(4.20M)	(6.63M)	(4.40M)	(3.02M)	[{"date":"2021-12-31","value":-419800000,"profit":false},{"date":"2022-12-31","value":-663000000,"profit":false},{"date":"2023-12-31","value":-440000000,"profit":false},{"date":"2024-12-31","value":-301900000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(4.20M)	(6.63M)	(4.40M)	(3.02M)	[{"date":"2021-12-31","value":-419800000,"profit":false},{"date":"2022-12-31","value":-663000000,"profit":false},{"date":"2023-12-31","value":-440000000,"profit":false},{"date":"2024-12-31","value":-301900000,"profit":false}]

EPS (Diluted)	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

	Dec '21	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	17.68%	(1.13%)	(26.49%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-6.4,"profit":false},{"date":"2024-12-31","value":-149.86,"profit":false}]
Operating Income	-	17.68%	(1.13%)	(26.49%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-6.4,"profit":false},{"date":"2024-12-31","value":-149.86,"profit":false}]
Total Non-Operating Income/Expense	-	73.88%	(49.48%)	(13.59%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-66.98,"profit":false},{"date":"2024-12-31","value":-18.39,"profit":false}]
Pre-Tax Income	-	57.93%	(33.63%)	(31.39%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-58.06,"profit":false},{"date":"2024-12-31","value":-54.18,"profit":false}]
Income Taxes	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	57.93%	(33.63%)	(31.39%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-58.06,"profit":false},{"date":"2024-12-31","value":-54.18,"profit":false}]
Income From Discontinued Operations	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	57.93%	(33.63%)	(31.39%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-58.06,"profit":false},{"date":"2024-12-31","value":-54.18,"profit":false}]

EPS (Diluted)	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Dec '21	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	2.65M	2.46M	1.84M	206.00K	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.01,"profit":true},{"date":"2023-12-31","value":69.45,"profit":true},{"date":"2024-12-31","value":7.78,"profit":true}]
Non-current Assets	6.78M	6.28M	6.41M	6.16M	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.6,"profit":true},{"date":"2023-12-31","value":94.47,"profit":true},{"date":"2024-12-31","value":90.8,"profit":true}]
Total Assets	9.43M	8.74M	8.25M	6.37M	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.72,"profit":true},{"date":"2023-12-31","value":87.45,"profit":true},{"date":"2024-12-31","value":67.49,"profit":true}]

Total Liabilities
Current Liabilities	6.29M	12.91M	14.26M	12.13M	[{"date":"2021-12-31","value":44.14,"profit":true},{"date":"2022-12-31","value":90.52,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":85.05,"profit":true}]
Non-current Liabilities	26.46M	25.47M	28.06M	30.76M	[{"date":"2021-12-31","value":86.04,"profit":true},{"date":"2022-12-31","value":82.8,"profit":true},{"date":"2023-12-31","value":91.24,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	32.76M	38.38M	42.32M	42.88M	[{"date":"2021-12-31","value":76.38,"profit":true},{"date":"2022-12-31","value":89.49,"profit":true},{"date":"2023-12-31","value":98.68,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.00K	1.00K	1.00K	1.00K	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(19.03M)	(25.66M)	(30.06M)	(33.08M)	[{"date":"2021-12-31","value":-1903100000,"profit":false},{"date":"2022-12-31","value":-2566100000,"profit":false},{"date":"2023-12-31","value":-3006100000,"profit":false},{"date":"2024-12-31","value":-3308000000,"profit":false}]
Other Stockholders' Equity	(4.56M)	(4.56M)	(4.56M)	(4.56M)	[{"date":"2021-12-31","value":-456100000,"profit":false},{"date":"2022-12-31","value":-456100000,"profit":false},{"date":"2023-12-31","value":-456100000,"profit":false},{"date":"2024-12-31","value":-456100000,"profit":false}]
Total Shareholders' equity	(23.32M)	(29.63M)	(34.07M)	(36.52M)	[{"date":"2021-12-31","value":-2332500000,"profit":false},{"date":"2022-12-31","value":-2963100000,"profit":false},{"date":"2023-12-31","value":-3407300000,"profit":false},{"date":"2024-12-31","value":-3651900000,"profit":false}]

Total Liabilities & Shareholders Equity	9.43M	8.74M	8.25M	6.37M	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.72,"profit":true},{"date":"2023-12-31","value":87.45,"profit":true},{"date":"2024-12-31","value":67.49,"profit":true}]

	Dec '21	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	-	(6.99%)	(25.33%)	(88.80%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Non-current Assets	-	(7.40%)	2.02%	(3.89%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-366.03,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-192.18,"profit":false}]
Total Assets	-	(7.28%)	(5.68%)	(22.82%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	105.07%	10.47%	(14.95%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":9.96,"profit":true},{"date":"2024-12-31","value":-14.23,"profit":false}]
Non-current Liabilities	-	(3.76%)	10.18%	9.60%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-36.88,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":94.29,"profit":true}]
Total Liabilities	-	17.15%	10.28%	1.33%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.93,"profit":true},{"date":"2024-12-31","value":7.77,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	34.84%	17.15%	10.04%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":49.22,"profit":true},{"date":"2024-12-31","value":28.83,"profit":true}]
Other Stockholders' Equity	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	27.04%	14.99%	7.18%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":55.45,"profit":true},{"date":"2024-12-31","value":26.55,"profit":true}]

Total Liabilities & Shareholders Equity	-	(7.28%)	(5.68%)	(22.82%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

	Dec '23	Jun '24	Dec '24
Total Assets
Current Assets	1.84M	200.00K	206.00K	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-06-30","value":10.88,"profit":true},{"date":"2024-12-31","value":11.2,"profit":true}]
Non-current Assets	6.41M	6.24M	6.16M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-06-30","value":97.36,"profit":true},{"date":"2024-12-31","value":96.11,"profit":true}]
Total Assets	8.25M	6.44M	6.37M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-06-30","value":78.08,"profit":true},{"date":"2024-12-31","value":77.18,"profit":true}]

Total Liabilities
Current Liabilities	14.26M	11.93M	12.13M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-06-30","value":83.7,"profit":true},{"date":"2024-12-31","value":85.05,"profit":true}]
Non-current Liabilities	28.06M	29.43M	30.76M	[{"date":"2023-12-31","value":91.24,"profit":true},{"date":"2024-06-30","value":95.69,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Liabilities	42.32M	41.37M	42.88M	[{"date":"2023-12-31","value":98.68,"profit":true},{"date":"2024-06-30","value":96.46,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	1.00K	1.00K	1.00K	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(30.06M)	(31.39M)	(33.08M)	[{"date":"2023-12-31","value":-3006100000,"profit":false},{"date":"2024-06-30","value":-3138700000,"profit":false},{"date":"2024-12-31","value":-3308000000,"profit":false}]
Other Stockholders' Equity	(4.56M)	(4.56M)	(4.56M)	[{"date":"2023-12-31","value":-456100000,"profit":false},{"date":"2024-06-30","value":-456100000,"profit":false},{"date":"2024-12-31","value":-456100000,"profit":false}]
Total Shareholders' equity	(34.07M)	(34.93M)	(36.52M)	[{"date":"2023-12-31","value":-3407300000,"profit":false},{"date":"2024-06-30","value":-3492600000,"profit":false},{"date":"2024-12-31","value":-3651900000,"profit":false}]

Total Liabilities & Shareholders Equity	8.25M	6.44M	6.37M	[{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-06-30","value":78.08,"profit":true},{"date":"2024-12-31","value":77.18,"profit":true}]

	Dec '23	Jun '24	Dec '24
Total Assets
Current Assets	-	(89.12%)	3.00%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":-2970.82,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	-	(2.64%)	(1.28%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Total Assets	-	(21.92%)	(1.15%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	(16.30%)	1.62%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":-1007.87,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	4.88%	4.51%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true},{"date":"2024-12-31","value":92.35,"profit":true}]
Total Liabilities	-	(2.26%)	3.67%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":-61.45,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Retained Earnings	-	4.41%	5.39%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":81.78,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	2.50%	4.56%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":54.89,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(21.92%)	(1.15%)	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	(1.98M)	(2.97M)	(2.60M)	(3.62M)	[{"date":"2021-12-31","value":-198400000,"profit":false},{"date":"2022-12-31","value":-297100000,"profit":false},{"date":"2023-12-31","value":-260100000,"profit":false},{"date":"2024-12-31","value":-362400000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(1.31M)	1.39M	95.00K	-	[{"date":"2021-12-31","value":-93.89,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.82,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	(1.38M)	3.33M	2.03M	1.99M	[{"date":"2021-12-31","value":-41.49,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":60.85,"profit":true},{"date":"2024-12-31","value":59.71,"profit":true}]

Net Change in Cash	(4.61M)	1.72M	(532.00K)	(1.64M)	[{"date":"2021-12-31","value":-267.38,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-30.88,"profit":false},{"date":"2024-12-31","value":-95.24,"profit":false}]

Free Cash Flow
Free Cash Flow	(2.12M)	(3.22M)	(2.60M)	(3.62M)	[{"date":"2021-12-31","value":-212100000,"profit":false},{"date":"2022-12-31","value":-321700000,"profit":false},{"date":"2023-12-31","value":-260100000,"profit":false},{"date":"2024-12-31","value":-362400000,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	-	49.75%	(12.45%)	39.33%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-25.03,"profit":false},{"date":"2024-12-31","value":79.06,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(206.50%)	(93.18%)	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(341.00%)	(39.15%)	(1.87%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Net Change in Cash	-	(137.40%)	(130.88%)	208.46%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-65.91,"profit":false},{"date":"2023-12-31","value":-62.78,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	51.67%	(19.15%)	39.33%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-37.06,"profit":false},{"date":"2024-12-31","value":76.11,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	MENS
Cash Ratio	0.01
Current Ratio	0.02

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	MENS
ROA (LTM)	-17.59%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	MENS
Debt Ratio Lower is generally better. Negative is bad.	6.74
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-5.74

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	MENS
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Jyong Biotech Ltd. Ordinary Shares share price today?

Jyong Biotech Ltd. Ordinary Shares (MENS) share price today is $52.31

Can Indians buy Jyong Biotech Ltd. Ordinary Shares shares?

Yes, Indians can buy shares of Jyong Biotech Ltd. Ordinary Shares (MENS) on Vested. To buy Jyong Biotech Ltd. Ordinary Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MENS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Jyong Biotech Ltd. Ordinary Shares be purchased?

Yes, you can purchase fractional shares of Jyong Biotech Ltd. Ordinary Shares (MENS) via the Vested app. You can start investing in Jyong Biotech Ltd. Ordinary Shares (MENS) with a minimum investment of $1.

How to invest in Jyong Biotech Ltd. Ordinary Shares shares from India?

You can invest in shares of Jyong Biotech Ltd. Ordinary Shares (MENS) via Vested in three simple steps:

Click on Sign Up or Invest in MENS stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Jyong Biotech Ltd. Ordinary Shares shares

What is Jyong Biotech Ltd. Ordinary Shares 52-week high and low stock price?

The 52-week high price of Jyong Biotech Ltd. Ordinary Shares (MENS) is $61. The 52-week low price of Jyong Biotech Ltd. Ordinary Shares (MENS) is $6.01.

What is Jyong Biotech Ltd. Ordinary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Jyong Biotech Ltd. Ordinary Shares (MENS) is 0.00

What is the Market Cap of Jyong Biotech Ltd. Ordinary Shares?

The market capitalization of Jyong Biotech Ltd. Ordinary Shares (MENS) is $4.19B

What is Jyong Biotech Ltd. Ordinary Shares’s stock symbol?

The stock symbol (or ticker) of Jyong Biotech Ltd. Ordinary Shares is MENS

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets Private Beta

Managed Portfolios (Previously Vests)

Global Mutual Funds Join Waitlist

Global

Explore our India Diversification

INR Bonds

Alt FDs

Jyong Biotech Ltd. Ordinary Shares, Common Stock

MENS

NMQ

$52.31

-$2.8

(-5.08%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Jyong Biotech Ltd. Ordinary Shares, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²